OTCMKTS:HTLZF Hamilton Thorne (HTLZF) Stock Price, News & Analysis $1.59 0.00 (0.00%) As of 07/21/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Hamilton Thorne Stock (OTCMKTS:HTLZF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hamilton Thorne alerts:Sign Up Key Stats Today's Range$1.59▼$1.5950-Day Range$1.59▼$1.5952-Week Range$0.90▼$1.63VolumeN/AAverage Volume29,614 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Hamilton Thorne Ltd. is a life sciences instrumentation company specializing in precision laser and imaging systems used in assisted reproduction and cell analysis applications. The company’s core focus lies in providing advanced tools for in vitro fertilization (IVF) laboratories, research institutions and biotechnology firms, offering solutions that enhance embryo manipulation, sperm immobilization and cell viability assessments. The company’s product portfolio centers on micromanipulation laser systems designed for tasks such as assisted hatching, embryo biopsy for pre-implantation genetic diagnosis, and zona drilling, enabling embryologists to perform delicate procedures with high accuracy. In addition to its laser platforms, Hamilton Thorne offers imaging and analysis software that streamlines cell counting, colony analysis and viability studies, supporting both clinical workflows and basic research in reproductive and stem cell biology. Headquartered in Beverly, Massachusetts, Hamilton Thorne serves a global customer base through a network of offices and distribution partners across North America, Europe and Asia Pacific. Under the leadership of Chief Executive Officer Michael Spinella, the company continues to invest in product development and strategic partnerships aimed at broadening the adoption of its technologies in fertility clinics, academic laboratories and pharmaceutical research settings.AI Generated. May Contain Errors. Read More Receive HTLZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hamilton Thorne and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HTLZF Stock News HeadlinesHamilton Thorne Goes Private, Delists from TSXNovember 29, 2024 | markets.businessinsider.comHamilton Thorne Ltd.: Hamilton Thorne Announces Shareholder Approval of Going Private TransactionSeptember 18, 2024 | finanznachrichten.deA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.July 22 at 1:00 AM | Porter & Company (Ad)Hamilton Thorne Announces Shareholder Approval of Going Private TransactionSeptember 17, 2024 | globenewswire.comHamilton Thorne Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private TransactionAugust 26, 2024 | globenewswire.comHamilton Thorne Reports Revenue for the Quarter and Six Months Ended June 30, 2024, and Confirms Annual GuidanceAugust 14, 2024 | globenewswire.comHamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024August 7, 2024 | globenewswire.comExploring TSX Stocks With Estimated Discounts Ranging From 12.9% To 23.6%July 23, 2024 | uk.finance.yahoo.comSee More Headlines HTLZF Stock Analysis - Frequently Asked Questions How have HTLZF shares performed this year? Hamilton Thorne's stock was trading at $1.5901 at the start of the year. Since then, HTLZF stock has increased by 0.0% and is now trading at $1.5901. How do I buy shares of Hamilton Thorne? Shares of HTLZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:HTLZF CIKN/A Webwww.hamiltonthorne.ltd Phone(978) 921-2050FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:HTLZF) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersAmerica’s answer to universal basic incomeRobert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTSM just handed Trump's secretive AI project $100 billionTaiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion a...InvestorPlace | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon is about to dominate the biggest arms race in tech historyMicrosoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...The Oxford Club | SponsoredWall Street legend put 60% in one stock — here’s the tickerOne of America's most famous investors put 60% of his fund into a single stock - and Whitney Tilson of Stansbe...Stansberry Research | SponsoredIt all happens tonight.Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...Trade Thirsty | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hamilton Thorne Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hamilton Thorne With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
